300 related articles for article (PubMed ID: 30223800)
1. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
2. Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.
Van Belle V; Van Calster B; Brouckaert O; Vanden Bempt I; Pintens S; Harvey V; Murray P; Naume B; Wiedswang G; Paridaens R; Moerman P; Amant F; Leunen K; Smeets A; Drijkoningen M; Wildiers H; Christiaens MR; Vergote I; Van Huffel S; Neven P
J Clin Oncol; 2010 Sep; 28(27):4129-34. PubMed ID: 20713855
[TBL] [Abstract][Full Text] [Related]
3. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.
Seneviratne S; Lawrenson R; Scott N; Kim B; Shirley R; Campbell I
PLoS One; 2015; 10(4):e0123523. PubMed ID: 25849101
[TBL] [Abstract][Full Text] [Related]
5. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
[TBL] [Abstract][Full Text] [Related]
6. Prognostic models in male breast cancer.
van der Pol CC; Lacle MM; Witkamp AJ; Kornegoor R; Miao H; Bouchardy C; Borel Rinkes I; van der Wall E; Verkooijen HM; van Diest PJ
Breast Cancer Res Treat; 2016 Nov; 160(2):339-346. PubMed ID: 27671991
[TBL] [Abstract][Full Text] [Related]
7. Prognostic models for breast cancer: a systematic review.
Phung MT; Tin Tin S; Elwood JM
BMC Cancer; 2019 Mar; 19(1):230. PubMed ID: 30871490
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer survival in New Zealand women.
Campbell ID; Scott N; Seneviratne S; Kollias J; Walters D; Taylor C; Webster F; Zorbas H; Roder DM
ANZ J Surg; 2015; 85(7-8):546-52. PubMed ID: 25266995
[TBL] [Abstract][Full Text] [Related]
9. A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer.
Tan W; Luo W; Jia W; Liang G; Xie X; Zheng W; Song E; Su F; Gong C
Oncotarget; 2016 Dec; 7(52):87312-87322. PubMed ID: 27894097
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.
Okugawa H; Yamamoto D; Uemura Y; Sakaida N; Yamada M; Tanaka K; Kamiyama Y
Surg Today; 2005; 35(11):907-11. PubMed ID: 16249842
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer.
Kerin EP; Davey MG; McLaughlin RP; Sweeney KJ; Barry MK; Malone CM; Elwahab SA; Lowery AJ; Kerin MJ
Breast; 2022 Dec; 66():227-235. PubMed ID: 36335747
[TBL] [Abstract][Full Text] [Related]
12. Are symptomatic guidelines for chemotherapy appropriate to ER-positive screen-detected breast cancer (SDBC)?
Bundred NJ; Prasad R; Morris J; Knox WF; Byrne G; Cheung S; Wilson M; Lawrence G
Breast Cancer Res Treat; 2013 Apr; 138(2):359-68. PubMed ID: 21744241
[TBL] [Abstract][Full Text] [Related]
13. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
[TBL] [Abstract][Full Text] [Related]
14. The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I-III Breast Cancer Patients Undergoing Surgical Treatment.
Wen J; Ye F; Li S; Huang X; Yang L; Xiao X; Xie X
PLoS One; 2015; 10(11):e0143537. PubMed ID: 26600129
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
[TBL] [Abstract][Full Text] [Related]
16. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
Wu X; Ye Y; Barcenas CH; Chow WH; Meng QH; Chavez-MacGregor M; Hildebrandt MA; Zhao H; Gu X; Deng Y; Wagar E; Esteva FJ; Tripathy D; Hortobagyi GN
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376179
[TBL] [Abstract][Full Text] [Related]
17. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia.
Miao H; Hartman M; Verkooijen HM; Taib NA; Wong HS; Subramaniam S; Yip CH; Tan EY; Chan P; Lee SC; Bhoo-Pathy N
BMC Cancer; 2016 Oct; 16(1):820. PubMed ID: 27769212
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Callagy GM; Pharoah PD; Pinder SE; Hsu FD; Nielsen TO; Ragaz J; Ellis IO; Huntsman D; Caldas C
Clin Cancer Res; 2006 Apr; 12(8):2468-75. PubMed ID: 16638854
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Nottingham Prognostic Index and Adjuvant Online prognostic tools in young women with breast cancer: review of a single-institution experience.
Hearne BJ; Teare MD; Butt M; Donaldson L
BMJ Open; 2015 Jan; 5(1):e005576. PubMed ID: 25628047
[TBL] [Abstract][Full Text] [Related]
20. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
